scispace - formally typeset
E

Evelyne Lerut

Researcher at Katholieke Universiteit Leuven

Publications -  223
Citations -  9555

Evelyne Lerut is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 42, co-authored 217 publications receiving 8321 citations. Previous affiliations of Evelyne Lerut include Rafael Advanced Defense Systems & Maastricht University.

Papers
More filters
Journal ArticleDOI

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').

TL;DR: The 8th Banff Conference on Allograft Pathology was held in Edmonton, Canada, 15–21 July 2005, and major outcomes included the elimination of the non‐specific term ‘chronic allograft nephropathy’ (CAN) and the recognition of the entity of chronic antibody‐mediated rejection.
Journal ArticleDOI

Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients.

TL;DR: The incidence of late acute rejections and changes in serum‐creatinine over time between compliers and noncompliers with immunosuppressive therapy more than 1 year post transplantation are compared and the relative contribution of non‐compliance and other risk factors are explored.
Journal ArticleDOI

Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

TL;DR: A precise overview of the lymphatic drainage pattern and to correlate those findings with dissemination patterns is presented and the impact of the extent of LND on N-staging and on the number of LN+ removed was calculated.
Journal ArticleDOI

CYP3A5 and CYP3A4 but not MDR1 Single-nucleotide Polymorphisms Determine Long-term Tacrolimus Disposition and Drug-related Nephrotoxicity in Renal Recipients

TL;DR: The lack of a time‐related increase in dose‐corrected tacrolimus exposure observed with the CYP3A4*1/CYP3A5*1 and CYP6*1B/Cyp3A 5*1 genotypes is associated with tac rolimus‐related nephrotoxicity, possibly as a result of higher concentrations of toxic metabolites.